📰 Given Genmab News
Given Genmab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Genmab. Real-time updates on events, politics, business and more.
February 25, 2024
Genmab A/S (NASDAQ:GMAB – Get Free Report) and Earth Science Tech (OTCMKTS:ETST – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings. Profitability This table compares Genmab A/S and […]
February 25, 2024
Earth Science Tech (OTCMKTS:ETST – Get Free Report) and Genmab A/S (NASDAQ:GMAB – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Earth Science Tech […]
February 7, 2024
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) and Genmab A/S (NASDAQ:GMAB – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Profitability This table compares NewAmsterdam Pharma and Genmab […]
February 1, 2024
Genmab A/S (NASDAQ:GMAB – Get Free Report) and NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Institutional & Insider Ownership 6.3% of Genmab A/S […]